Pharmaceutics International Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Pharmaceutics International Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011825
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥28,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥56,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥84,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pharmaceutics International Inc (PII) is a contract development and manufacturing company that offers dosage form development and cGMP manufacturing services. The company offers manufacturing of drugs such as dosage forms of solid, semi-solid, liquid, inhalation, parenteral and aseptic filling. Its services comprise drug substance optimization, preformulation testing, dosage form development, CTM manufacturing, commercial manufacturing, clinical packaging and labeling, clinical trial kit building and distribution, among others. PII also offers API characterization and solid state screening, dosage form development, pre-formulation testing, CTM manufacturing and commercial manufacturing programs. The company serves its clients in the US and abroad. PII is headquartered in Hunt Valley, Maryland, the US.

Pharmaceutics International Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Pharmaceutics International Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Pharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Pharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Pharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Pharmaceutics International Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Pharmaceutics International Raises USD10 Million in Venture Financing 10
Pharmaceutics International Raises USD93 Million in Venture Financing 11
Partnerships 13
Breckenridge Pharma Enters into Co-Development Agreement with Pharmaceutics International 13
Pharmaceutics International Inc – Key Competitors 14
Pharmaceutics International Inc – Key Employees 15
Pharmaceutics International Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Legal and Regulatory 17
Sep 16, 2016: Pharmaceutics International US: supply of non-critical medicines to EU to be stopped due to manufacturing failings 17
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Pharmaceutics International Inc, Pharmaceuticals & Healthcare, Key Facts 2
Pharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Pharmaceutics International Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Pharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Pharmaceutics International Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Pharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Pharmaceutics International Raises USD10 Million in Venture Financing 10
Pharmaceutics International Raises USD93 Million in Venture Financing 11
Breckenridge Pharma Enters into Co-Development Agreement with Pharmaceutics International 13
Pharmaceutics International Inc, Key Competitors 14
Pharmaceutics International Inc, Key Employees 15
Pharmaceutics International Inc, Other Locations 16

★海外企業調査レポート[Pharmaceutics International Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • John Paul Mitchell Systems, Inc.:企業の戦略・SWOT・財務分析
    SummaryJohn Paul Mitchell Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the com …
  • University of Melbourne-医療機器分野:企業M&A・提携分析
    Summary The University of Melbourne is an educational service provider that offers graduate, postgraduate, and research degrees. The university offers education in various fields which include arts, engineering, business and economics, architecture, building and planning, land and environment, medic …
  • Apar Industries Limited (APARINDS):企業財務及び戦略的SWOT分析
    Summary Apar Industries Limited (AIL) is an oil and gas company that develops electrical equipment. The company’s product includes specialty oils and lubricants, aluminium and alloy conductors, electrical and telecom cables, automotive lubricants, and polymers. It develops specialty oil such as tran …
  • Virbac Corporation:企業の戦略・SWOT・財務分析
    SummaryVirbac Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Find …
  • Australian Renewable Fuels Limited (ARW):企業のM&A・提携動向(石油・ガス分野)
    Summary Australian Renewable Fuels Limited (ARfuels) is an independent biodiesel producer. It produces, processes and distributes biodiesel. The company produces biodiesel using feedstocks such as tallow, vegetable oils and used cooking oils. It uses Energea process for production of biodiesel. The …
  • Empresa Distribuidora y Comercializadora Norte S.A. (EDN):企業のM&A・提携動向(発電分野)
    Summary Empresa Distribuidora y Comercializadora Norte S.A. (Edenor), a subsidiary of Pampa Energia SA, distributes and sells electricity in Argentina. The company distributes electricity under concession agreement in the northwestern zone of the greater Buenos Aires metropolitan area and in the nor …
  • EG A/S (formerly EDB Gruppen):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' EG A/S (formerly EDB Gruppen) M …
  • Sompo Holdings, Inc. (8630):企業の財務・戦略的SWOT分析
    Sompo Holdings, Inc. (8630) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Accel Frontline Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Accel Frontline Limited Mergers …
  • SE-Education Public Company Limited (SE-ED):企業財務及び戦略的SWOT分析
    Summary SE-Education Public Company Limited (SE-ED) is a books retailing company that publishes and distributes books and magazines. The company offers books and magazines related to science, management, business, and general knowledge. It sells advertising space, and provides printing service for o …
  • Taihei Dengyo Kaisha, Ltd. (1968):企業財務及び戦略的SWOT分析
    Summary Taihei Dengyo Kaisha, Ltd. (Taihei Dengyo) is an engineering and construction company that provides engineering, construction, repair and maintenance services. Its business activities consists of the design, project, inspection and fabrication activities in engineering; construction of therm …
  • Technics Oil & Gas Limited (5CQ):企業概要、財務及び戦略的SWOT分析
    Summary Technics Oil & Gas Limited (Technics) is an oil and gas company. The company offers one stop oil and gas solutions. It concentrates in the design and fabrication of complex and customized process equipments and modules, including gas compression packages, which are integrated to form the ope …
  • Sumitomo Corporation of America:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Sumitomo Corporation of America …
  • QLogic Corporation (QLGC):企業概要、財務及び戦略的SWOT分析
    Summary QLogic Corporation (QLogic) is a semiconductor product manufacturer. The company’s products include fiber channel adapters, intelligent ethernet adapters, iSCSI Adapters, converged network adapters, fiber channel switches, converged network switches, intelligent storage routers, fiber channe …
  • China Shipbuilding Industry Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' China Shipbuilding Industry Cor …
  • Orzel Bialy S.A. (OBL):企業概要、財務及び戦略的SWOT分析
    Summary Orzel Bialy S.A. (Orzel Bialy) is a recycling service provider. The company provides recycling of used lead batteries. It recycles lead accumulators and lead products for domestic and export markets. Orzel Bialy’s lead products are classified as pure lead, soft lead, lead alloy and lead calc …
  • Pfizer, Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Pfizer, Ltd. Mergers and Acquis …
  • Veropharm (VRPH):企業概要、財務及び戦略的SWOT分析
    Summary Veropharm is a pharmaceutical company. The company develops and manufactures generic pharmaceutical drugs, oncological medications, and medical adhesive bandages. It operates through three plants, such as Voronezh Chemical-Pharmaceutical Plant, Belgorod and Basil plant, and Pokrov ready-made …
  • ChoongAng Vaccine Laboratory (072020):企業財務及び戦略的SWOT分析
    Summary ChoongAng Vaccine Laboratory (CAVAC) is a healthcare company that offers animal biological products. The company manufactures and commercializes animal vaccines and diagnostic kits. Its product portfolio includes animal health vaccines and solutions, such as suishot, poulshot, canishot, bovi …
  • Basic Energy Services, Inc. (BAS):企業の財務及び戦略的SWOT分析
    Summary Basic Energy Services, Inc. (Basic) is an oil and gas company that provides well site services to oil and natural gas drilling. The company’s services include well servicing, fluid services, pumping services, pumping services, rental and fishing tools, contract drilling, wireline, snubbing s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆